iNOS in Macrophage Polarization: Pharmacological and Regulatory Insights
International Journal of Molecular Sciences · 15.12.2025 · 26 (24) · 12056
DOI: 10.3390/ijms262412056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.12.2025. Verfasst von Ji-Hye Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, College of Medical Science, Soonchunhyang University, Asan 31538, Chungnam, Republic of Korea. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type II, Macrophages, Macrophage Activation. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Macrophages play a central role in orchestrating inflammation and immune responses, with their polarization states (M1 or M2) exhibiting both pro- and anti-inflammatory, as well as anti-cancer functions. Inducible nitric oxide synthase (iNOS) plays a pivotal role in immune regulation through its impact on macrophage polarization. As a hallmark of M1 macrophages, iNOS drives pro-inflammatory responses, while its suppression favors anti-inflammatory M2 phenotypes. This dual role as both a biomarker and regulatory hub positions iNOS as a promising therapeutic target across diverse disease states. This review examines the roles of iNOS modulation in macrophage polarization across various disease models. Both synthetic and natural iNOS regulators have been shown to modulate iNOS activity, thereby reprogramming macrophages toward either inflammatory or reparative phenotypes. We categorize these regulators into those that directly inhibit enzymatic activity and those that indirectly modulate through signaling pathways. Additionally, recent preclinical and clinical studies on iNOS inhibitors are summarized, highlighting their therapeutic potential in inflammatory, metabolic, and oncologic diseases. Taken together, the evidence underscores the therapeutic relevance of iNOS regulation as a strategy to reprogram macrophage plasticity in disease-specific immune microenvironments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, College of Medical Science, Soonchunhyang University, Asan 31538, Chungnam, Republic of Korea.
- Department of Occupational Therapy, College of Medical Science, Soonchunhyang University, Asan 31538, Chungnam, Republic of Korea.
- Institute for Molecular Metabolism Innovation, Soonchunhyang University, Asan 31538, Chungnam, Republic of Korea.
- Department of Medical Science, College of Medical Science, Soonchunhyang University, Asan 31538, Chungnam, Republic of Korea.
ORCID-Profile: Ji-Hye Kang, Ji-Hee Kim, Jeong-An Gim, Mi-Young Lee
Förderung
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Kang, J. H., Kim, J. H., Gim, J. A., & Lee, M. Y. (2025). iNOS in Macrophage Polarization: Pharmacological and Regulatory Insights. International Journal of Molecular Sciences, 26(24), 12056. https://doi.org/10.3390/ijms262412056
Vancouver
Kang JH, Kim JH, Gim JA, Lee MY. iNOS in Macrophage Polarization: Pharmacological and Regulatory Insights. International Journal of Molecular Sciences. 2025;26(24):12056. doi:10.3390/ijms262412056
BibTeX
@article{Kang2025,
author = {Kang, Ji-Hye and Kim, Ji-Hee and Gim, Jeong-An and Lee, Mi-Young},
title = {iNOS in Macrophage Polarization: Pharmacological and Regulatory Insights},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {24},
pages = {12056},
doi = {10.3390/ijms262412056}
}
EUVIMED